| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |